5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MSK-ACCESS for the detection of fibroblast growth factor receptor-3 (FGFR3) mutations in plasma cell-free (cf)DNA of metastatic urothelial carcinoma (mUC) patients (pts) pre- and on erdafitinib (erda) therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Al-Ahmadie, H.; Brannon, A. R.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Nacev, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • INDIGO: A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) with residual or recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation
    Meeting Abstract

    Mellinghoff, I. K.; Van den Bent, M. J.; Clarke, J. L.; Maher, E. A.; Peters, K. B.; Touat, M.; De Groot, J. F.; De La Fuente, M. I.; Arrillaga-Romany, I.; Wick, W.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers
    Meeting Abstract

    Kirtane, K.; Massarelli, E.; Hanna, G. J.; Klebanoff, C. A.; Blumenschein, G.; Bishop, M. R.; Lee, S.; Niu, J.; Adhikary, S.; Astrow, S. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity
    Meeting Abstract

    Connell, L. C.; Fiedler, L.; Dickinson, S.; Ly, M.; Harrington, K.; Jarnagin, W. R.; Kingham, T. P.; Drebin, J. A.; Balachandran, V. P.; Wei, A. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Buxton, M. B.; Alexander, B. M.; Berry, D. A.; Cavenee, W. K.; Colman, H.; De Groot, J. F.; Ellingson, B. M.; Gordon, G. B.; Khasraw, M.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
    Meeting Abstract

    Zhang, Z.; Zhou, C.; Li, X.; Barnes, S.; Deng, S.; Hoover, E.; Chen, C. C.; Lee, Y. S.; Wang, C.; Tirado, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Rapid non-uniform adaptation to conformation-specific KRAS G12Cinhibition
    Meeting Abstract

    Xue, J. Y.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The protein phosphatase 4 complex is a tumor suppressor in prostate cancer
    Meeting Abstract

    Watson, P. A.; Lawrence, K. E.; Nadkarni, T. V.; Ishmael, T. F.; Lee, E.; Agudelo Rivera, A. C.; Love, J. R.; Wongvipat, J.; Cai, L.; Nazir, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save